Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1999-3-16
pubmed:abstractText
The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa. To better understand the oedema-reducing effect of AZM, the effect of AZM on passive permeability and active transport of fluorescein across the blood-retina barrier was studied in patients with retinitis pigmentosa and varying degrees of macular oedema.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0721-832X
pubmed:author
pubmed:issnType
Print
pubmed:volume
236
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
881-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9865617-Acetazolamide, pubmed-meshheading:9865617-Adult, pubmed-meshheading:9865617-Biological Transport, Active, pubmed-meshheading:9865617-Blood-Retinal Barrier, pubmed-meshheading:9865617-Carbonic Anhydrase Inhibitors, pubmed-meshheading:9865617-Cross-Over Studies, pubmed-meshheading:9865617-Double-Blind Method, pubmed-meshheading:9865617-Female, pubmed-meshheading:9865617-Fluorescein, pubmed-meshheading:9865617-Fluorescein Angiography, pubmed-meshheading:9865617-Fluoresceins, pubmed-meshheading:9865617-Fluorophotometry, pubmed-meshheading:9865617-Fundus Oculi, pubmed-meshheading:9865617-Humans, pubmed-meshheading:9865617-Macular Edema, pubmed-meshheading:9865617-Male, pubmed-meshheading:9865617-Middle Aged, pubmed-meshheading:9865617-Retina, pubmed-meshheading:9865617-Retinitis Pigmentosa
pubmed:year
1998
pubmed:articleTitle
The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
pubmed:affiliation
University of Copenhagen, Herlev Sygehus, Department of Ophthalmology, Denmark.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't